FDA issued a Warning Letter to Kyowa Hakko Bio Co., Ltd. on 8/10/2018 as a result of this inspection.
483 Kyowa Hakko Bio Sep 2017
483 Kyowa Hakko Bio Sep 2017
Milva Melendez FDA$119.00 - Available NowFDA investigators audited the Kyowa Hakko Bio - Hofu, Japan facility and issued inspectional observations (via FDA 483) on 08 Sep 2017.
Product details
- Category: Human Drugs
- Inspection end: 08 Sep 2017
- Location: Hofu, Japan
- FEI: 3002807424
